GFRA3 and craniopharyngioma: We know that RET and GFRα3 expression is lost in craniopharyngiomas (39), a pituitary benign neoplasia possibly derived of some stem cell population where β-catenin activation and nuclear localization (28), either through mutation (42) or BRAF kinase activation (43), has been described.